New therapy granted a Promising Innovative Medicine designation by UK agency
News
GSK’s Nucala approved in the US for hypereosinophilic syndrome
Treatment becomes first and only biologic for HES in the US
Sosei Heptares scores $5m milestone payment from Pfizer
First subject dosed with new drug candidate from strategic collaboration
Novel nasal spray reduces COVID-19 viral replication in animal study
Treatment is being developed by Australian biotech Ena Respiratory
Novacyt signs deal with UK government for COVID-19 testing kits
First phase will see company deploy 300 PCR instruments to the UK
Accenture reveals data science project for paediatric leukaemia
Insights from project could potentially improve precision medicine use for paediatric AML
First UK patient given GSK’s experimental arthritis drug in COVID-19 trial
Drug is being investigated in up to 800 hospitalised patients nationwide
Gilead’s oral JAK inhibitor filgotinib wins EU approval
Treatment is indicated for use in adults with moderate-to-severe active rheumatoid arthritis
ABPI and EFPIA call for medicines prioritisation in UK/EU trade talks
Pharma industry bodies call for medicine supply to be safeguarded in upcoming talks
Accord Healthcare launches Herceptin biosimilar in the UK
Zercepac will be available for HER2-positive breast and gastric cancers
Monte Rosa Therapeutics raises $96m to develop protein-degrading molecules
ICR and Cancer Research UK spinout closes Series B financing
UK consumers seeking advice from pharmacists during pandemic, research finds
Survey commissioned by Johnson & Johnson for World Pharmacists Day
Novavax begins phase III coronavirus vaccine trial in the UK
Trial is being conducted in partnership with UK government’s Vaccines Taskforce
Oncimmune partners with Genentech to profile samples from rheumatology trials
UK-headquartered company will characterise autoantibody profiles of clinical trial patients
Verona Pharma launches late-stage COPD trial programme
Phase III trial programme will evaluate nebulised ensifentrine in moderate-to-severe COPD
